Kevin Downey, an attorney for Holmes, told the judge on Wednesday that they were concerned that unsealing the jury's questionnaires at this point could interfere with the right to Holmes on a fair try. "Some of the comments [by the jurors] raise concerns," Downey said.
"We need to make sure that we do not have jurors reporting a reaction to what is affecting their ability to serve, "Downey told the judge. Davila said he would hold hearings over the next five weeks to decide whether the questionnaires would be unsealed.
Jurors filled out an extensive 28-page questionnaire that asked them about their media exposure, theTheir opinions on health care, capital investment adventure, religious beliefs and other matters.
The form also includes the juror's name, level of education, profession, criminal record and educational background. 'other personal information.
"I think jurors will be wrong in caring about what is being made public, this is a high profile trial and they know they are are under scrutiny "said NBC News Legal Analyst Danny Cevallos.
Cevallos said it was not common to unseal jurors' questionnaires mid-trial, but "The media are now interested in what is going on with this jury.
The jury that decides Holmes' fate is made up of eight men and four women as well as three alternates. Last week, a juror was removed from his post after revealing that she was a Buddhist and had concerns about voting for a prison sentence.
"When they didanswered the questionnaires, they probably had no idea what it would be bursting out to the rest of the world "said Cevallos. " It might make them uncomfortable. "
Holmes, a Stanford dropout who founded Theranos at the age of 19, faces up to 20 years in prison and a $ 3 million fine if convicted. Prosecutors allege that she engaged in multi-million dollar fraud by misleading investors and patients about her company's blood testing technology. Holmes has pleaded not guilty.
To At its peak, Theranos was valued at $ 9 billion. Holmes once attracted global business and political leaders who invested in Theranos and served on the board. Many of them are witnesses in his criminal trial.
Former Walgreens CFO, Wade Miquelon, spoke after the morning delay. MiquelJurors were told that Walgreens invested $ 140 million in Theranos, placing Edison blood testing machines in 40 stores in Arizona and California.
Miquelon testified that he was told that in-store testing centers "would be better, faster, cheaper. " The executive, who worked at Walgreens from 2008 to 2014, said he understood that customers ' "blood would be tested on the Edison device. "
Walgreens ended its partnership with Theranos in 2016 and ultimately sued the Silicon Valley startup for breach of contract.
Miquelon was the second retail executive jurors have heard during the trial. Former Safeway CEO Steve Burd testified for two days about being initially seduced by Holmes, but felt frustrated with the nearly $ 400 million partnership afters repeated delays in deployment.
Disclosure: NBCUniversal is the parent company of CNBC.